Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.

Kamelgarn M, Chen J, Kuang L, Jin H, Kasarskis EJ, Zhu H.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11904-E11913. doi: 10.1073/pnas.1810413115. Epub 2018 Nov 19.

2.

Clinical and experimental studies of a novel P525R FUS mutation in amyotrophic lateral sclerosis.

Kuang L, Kamelgarn M, Arenas A, Gal J, Taylor D, Gong W, Brown M, St Clair D, Kasarskis EJ, Zhu H.

Neurol Genet. 2017 Jul 20;3(4):e172. doi: 10.1212/NXG.0000000000000172. eCollection 2017 Aug.

3.

Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.

Kamelgarn M, Chen J, Kuang L, Arenas A, Zhai J, Zhu H, Gal J.

Biochim Biophys Acta. 2016 Oct;1862(10):2004-14. doi: 10.1016/j.bbadis.2016.07.015. Epub 2016 Jul 25.

4.

Subcellular localization and RNAs determine FUS architecture in different cellular compartments.

Yang L, Zhang J, Kamelgarn M, Niu C, Gal J, Gong W, Zhu H.

Hum Mol Genet. 2015 Sep 15;24(18):5174-83. doi: 10.1093/hmg/ddv239. Epub 2015 Jun 29.

5.

Cytoskeleton targeting value in prostate cancer treatment.

Martin SK, Kamelgarn M, Kyprianou N.

Am J Clin Exp Urol. 2014 Apr 5;2(1):15-26. eCollection 2014. Review.

Supplemental Content

Loading ...
Support Center